Orodispersible liquisolid system is the combination of liquisolid technique and orodispersible system. The poor dissolution rate of water insoluble drug is a major drawback for the development of pharmaceutical dosage forms. The oral absorption of drug is most often controlled by dissolution in the gastrointestinal tract. Liquisolid system has been used to enhance dissolution rate of poorly water-soluble drugs. Orodispersible tablets are given in order to provide fast action by disperse in the mouth, without the need of water and make them compliance for paediatric and geriatric patients and to bypass the liver metabolism.
INTRODUCTION
The oral route remains the preferred route of drug administration due to its convenience, good patient compliance and low production costs. In order for a drug to be absorbed into the systemic circulation following oral administration, the drug must be dissolved in the gastric fluids (Munke and Nagarsenker, 2004) . For hydrophobic drugs, the dissolution process acts as the rate-controlling step and which determines the rate and degree of absorption. Bioavailability of poorly water soluble drugs is limited by their solubility and dissolution rate (Nazzal and Khan, 2006) Liquisolid technique is a new and promising method that can change the dissolution rate of drugs. It has been used to enhance dissolution rate of poorly water-soluble drugs. The new 'liquisolid'' technique may be applied to formulate liquid medications (i.e. oily liquid drugs and solutions, suspensions or emulsions of water-insoluble solid drugs carried in non-volatile liquid vehicles) into powders suitable for tableting or encapsulation. Since, the liquisolid tablets contain a solution of the drug in suitable solvent; the drug surface available for dissolution is tremendously increased (Javadzadeh and Nokhodchi, 2008) The concept of orodispersible tablet emerged with an objective to improve patient's compliance. These dosage forms rapidly disintegrate and/or dissolve to release the drug as soon as they come in contact with saliva, thus without the need for water during administration, an attempts that makes them highly attractive for paediatric and geriatric patients (Kaushik et al 2004) . When put in the mouth, these dosage forms disintegrate instantly to release the drug, which dissolves or disperses in the saliva. Thereafter, the drug may get absorbed from the pharynx and oesophagus or from other sections of GIT as the saliva travels down. In such cases, bioavailability is significantly greater than that observed from conventional tablet dosage form (Mudgal and Singhai, 2011) 
LIQUISOLID SYSTEM
This technique was first introduced by Spireas et al. and applied to incorporate water insoluble drugs into rapid release solid dosage forms. The term "liquisolid compacts" as described by Spireas et.al indicates that immediate or sustained release tablets or capsules that are prepared using the technique of "liquisolid systems" combined with the inclusion of appropriate adjuvants required for tabulating or encapsulation such as lubricants and for rapid or 
CONCEPT OF LIQUISOLID SYSTEM
When the drug dissolved in the liquid vehicle is incorporated into a carrier material which has a porous surface and closely matted fibres in its interior such as celluloses, both absorption and adsorption take place. The liquid initially absorbed in the interior of the particles is captured by its internal structure. After the saturation of this process, adsorption of the liquid onto the internal and external surfaces of the porous carrier particles occurs. Then, the coating material having high adsorptive properties and large specific surface area provides the liquisolid system the desirable flow characteristics (Sambasiva and Naga, 2011) . In liquisolid systems, the drug is already in solution form in liquid vehicle, while at the same time, it is carried by powder. The wettability of the compacts in the dissolution media is one of the proposed mechanisms for explaining the enhanced dissolution rate from the liquisolid compacts.
FIG-1:THEORETICAL CONCEPT OF LIQUISOLID SYSTEM
Non-volatile solvent present in the liquisolid system facilitates wetting of drug particles by decreasing interfacial tension between dissolution medium and tablet surface. 
Flowable liquid retention potential values (Ф-value)
The flowable liquid retention potential (Φ-value) of a powder is defined as the maximum amount of a given non-volatile liquid that can be retained inside its bulk (w/w) while maintaining acceptable flowability. Therefore, in order to calculate the quantity of excipients, we need to determine the liquid retention potential value for both carrier (Ф CA -value) and coating (Ф CO -value) materials for each formulation. These values are constant for the given vehicle/powder system.
Liquid loading factors (Lf)
It is defined as the weight ratio of the liquid formulation (W) and the carrier material (Q) in the system: Lf = W/Q------(1) (W is the weight of the liquid medication (the drug + nonvolatile liquid vehicle) and Q is the weight of the carrier.) R represents the ratio between the weights of the carrier (Q) and the coating (q) material present in the formulation. Then optimum weight of the coating material (q) could also be obtained (Equation 2).
R =Q/q------(2)
The liquid load factor that ensures acceptable flowability (Lf) can be determined by:
By calculating Lf and W, we can calculate the amount of Q and required for the liquisolid system Vol. 6, Issue 6 | www.pharmatutorjournal.com 
COMPONENTS OF LIQUISOLID SYSTEMS
The major formulation components of liquisolid compacts are (Yadav et al., 2010)
Carrier Material
These are compression-enhancing, relatively large, preferably porous particles possessing a sufficient absorption property which contributes in liquid absorption. E.g. various grades of cellulose, starch, lactose, sorbitol, Avicel PH 102 and 200, Eudragit RL and RS, amorphous cellulose etc.
Coating Material
These are flow-enhancing, very fine (10 nm to 5,000 nm in diameter), highly adsorptive coating particles (e.g., silica of various grades like Cab-O-Sil M5, Aerosil 200, Syloid 244FP etc.) contributes in covering the wet carrier particles and displaying a dry-looking powder by adsorbing any excess liquid.
Non-Volatile Solvents
Inert, high boiling point, preferably water-miscible and not highly viscous organic solvent systems. Various non-volatile solvents used for the formulation of liquisolid systems include Polyethylene glycol 200 and 400, glycerin, polysorbate 80 and propylene glycol, polysorbates, glycerin, N, N-dimethylacetamide, fixed oils, etc.
Disintegrant
Superdisintegrants increases the rate of drug release, water solubility and wettability of liquisolid granules. Mostly Superdisintegrants like sodium starch glycolate and crosspovidone and croscarmellose sodium are used.
MECHANISMS OF ENHANCEMENT OF SOLUBILITY AND BIOAVAILABILITY
Several mechanisms of enhanced drug release have been postulated for liquisolid systems (Saharan, 2009 ). The three main proposed mechanisms include increased surface area of drug available for release, increased aqueous solubility of the drug due to presence of non-volatile vehicle and improved wettability of the drug particles due to co solvent effect of the vehicle used.
A. Increased Effective Surface Area
If the drug within the liquisolid system is completely dissolved in the liquid vehicle, it is located in the powder substrate still in a solubilized and molecularly dispersed state. Therefore, the surface area of drug available for release is much greater than that of drug particles within directly compressed tablets. Accordingly, with increasing drug content exceeding the solubility limit and thus, increasing fraction of undissolved drug in the liquid vehicle the release rate decreases. With various drugs it could be shown that the release rates are directly proportional to the fraction of the molecularly dispersed drug (FM) in the liquid formulation. FM is defined by Spireas as the ratio between the drug's solubility (Sd) in the given liquid vehicle and the actual drug concentration (Cd) in this vehicle carried by each system. Therefore, FM = Sd/ Cd (4)
In addition it is thought that the adsorption and absorption of molecularly dispersed drug onto the surface and interior of the carrier particles impart increased effective surface area available for the mass transfer during the drug dissolution process.
B. Increased Aqueous Solubility
In addition to the first mechanism of drug release enhancement, it is expected that the solubility of the drug might be increased with liquisolid systems. In fact, the relatively small amount of liquid vehicle in a liquisolid compact is not sufficient to increase the overall solubility of the drug in the aqueous medium. However, in the micro-environment of the Vol. 6, Issue 6 | www.pharmatutorjournal.com solid/liquid interface between an individual primary liquisolid particle and the release medium, it is possible that the amount of liquid vehicle diffusing out of a single liquisolid particle together with the drug molecules might be sufficient to increase the aqueous solubility of the drug if the liquid vehicle can act as a cosolvent.
C. Improved Wetting Properties
Due to the fact that the liquid vehicle can either act as surface active agent or has a low surface tension, wetting of the primary liquisolid particles is improved.
FIG-2: WETTING PROPERTY OF LIQUISOLID SYSTEM.
Wettability of these systems can be demonstrated by contact angles and water rising times. Also the adsorption of the drug on the carrier particles increases the effective surface area, improving the contact of drug and wettability. Bitter taste can be masked with enough sweetener and flavors.  Drugs in form of ODTs are hygroscopic in nature and hence need to be protected from humidity (Kumar et al., 2012) . To overcome humidity problem special working facilities can be designed by simple methods and special airconditioning systems can be set up.  Size of tablet -7mm is easy to swallow while tablets of size 8mm are easy to handle. Hence, tablet sizes which are both easy to handle and swallow are difficult to achieve. For the patient compliance, to make the swallowing easier, round shape punches having optimum dimensions are used.  Drug candidates should be stable both in water and in saliva, should not ionize at oral cavity pH and should be able to permeate oral mucosal tissue to diffuse and partition in upper GI epithelium (logP > 1, or preferably > 2, should not have short half-life). To optimize solubility problem of the active pharmaceutical ingredient some solid buffers and surfactants can also be chosen. 
ADVANTAGES

METHOD OF PREPARATION OF ORODISPERSIBLE LIQUISOLID SYSTEM
As shown in figure-3, a liquid drug can be converted into a dry liquisolid system without being further chemically modified. If liquisolid system of a solid water-insoluble drug is to be formulated, it should be initially dissolved or suspended in a suitable non-volatile solvent system to produce a drug solution or drug suspension of desired concentration (Hamsanandini et al., 2015) Next, a certain amount of the prepared drug solution or suspension or a liquid drug itself is incorporated into a specific quantity of carrier material which should be preferably of a porous nature and possessing sufficient absorption properties.
The resulting wet mixture is then converted into a dry, non adherent, free-flowing and readily compressible powder by the simple addition and mixing of a calculated amount of coating material Excipients possessing fine and highly adsorptive particles are suitable for this step. Before compression or encapsulation, various adjuvants like lubricants and super-disintegrants added to final liquisolid system to produce orodispersible liquisolid compacts. 
FIG-3: STEPS INVOLVED IN THE PREPARATION OF LIQUISOLID SYSTEM
Determination of flowable liquid retention potential (Φ-value)
The term "flowable liquid-retention potential" (Φ-value) of a powder material describes its ability to retain a specific amount of liquid while maintaining good flow properties (Spireas and Bolton, 1999 
SOLUBILITY AND DISSOLUTION IMPROVEMENT
This technique was successfully applied for low dose water insoluble drugs. When the therapeutic dose of drug is more than 50mg, dissolution enhancement in the presence of low levels of hydrophilic carrier and coating material is not significant. But by adding some materials such as polyvinyl pyrrolidone (PVP) to liquid medication (microsystems), it would be possible to produce dry powder formulations containing liquid with high concentration of drug. By adding such materials to the liquid medication, low amount of carrier is required to obtain dry powder with free flowability and good compatibility (Amrit et al., 2009 ).
BIOAVAILABILITY IMPROVEMENT
In the liquisolid and powdered solution systems the drug might be in a solid dosage form, it is held within the powder substrate in solution, or in a solubilized, almost molecularly dispersed state. Therefore, due to their significantly increased wetting properties and surface of drug available for dissolution, liquisolid compacts of water insoluble substances may be expected to display enhanced drug release properties, and consequently, Improved bioavailability (Yadav VB and Yadav AV., 2009)
CONCLUSION
The Liquisolid system is a technique for formulation of water insoluble drugs to enhance their aqueous solubility, absorption as well as dissolution rate which leading to enhancement of bioavailability of drugs as compared to conventional directly compressed tablets. Orodispersible tablets may give rapid onset of action by rapid absorption through pre-gastric absorption of drug from mouth, pharynx and oesophagus as saliva passes down and beneficial to reduce dose. By combining Liquisolid technique and Orodispersible DDS, may enhance solubility, dissolution rate by means of Liquisolid technique and can achieve rapid onset of action with lower dose of drug by using Orodispersible DDS and hence may increase patient compliance.
